Lorenzo, A. D., Bolli, E., Ruiu, R., Ferrauto, G., Gregorio, E. D., Avalle, L., . . . Conti, L. (2022). Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationLorenzo, Antonino Di, et al. Toll-like Receptor 2 Promotes Breast Cancer Progression and Resistance to Chemotherapy. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationLorenzo, Antonino Di, et al. Toll-like Receptor 2 Promotes Breast Cancer Progression and Resistance to Chemotherapy. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.